Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data.

Sandecka, Viera; Pour, Ludek; Spicka, Ivan; Minarík, Jirí; Radocha, Jakub; Jelínek, Tomás; Pavlícek, Petr; Jungová, Alexandra; Kessler, Petr; Wróbel, Marek; Stork, Martin; Straub, Jan; Pika, Tomás; Cápková, Lenka; Sevcíková, Sabina; Maisnar, Vladimír; Hájek, Roman

Sandecka, Viera; Pour, Ludek; Spicka, Ivan; Minarík, Jirí; Radocha, Jakub; Jelínek, Tomás; Pavlícek, Petr; Jungová, Alexandra; Kessler, Petr; Wróbel, Marek; Stork, Martin; Straub, Jan; Pika, Tomás; Cápková, Lenka; Sevcíková, Sabina; Maisnar, Vladimír; Hájek, Roman.

Affiliation

Sandecka V; Department of Internal Medicine, Hematology and Oncology, University Hospital, Brno, Czech Republic.
Pour L; Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Spicka I; Department of Internal Medicine, Hematology and Oncology, University Hospital, Brno, Czech Republic.
Minarík J; Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Radocha J; 1st Department of Medicine-Department of Hematology, First Faculty of Medicine, Charles University and General Hospital,, Prague, Czech Republic.
Jelínek T; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
Pavlícek P; 4th Department of Internal Medicine-Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic.
Jungová A; Department of Hematooncology, University Hospital, Ostrava, Czech Republic.
Kessler P; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
Wróbel M; Department of Internal Medicine and Hematology, 3rd Faculty of Medicine, Charles University and Faculty Hospital Kralovske Vinohrady, Prague, Czech Republic.
Stork M; Hematology and Oncology Department, Charles University Hospital Pilsen, Pilsen, Czech Republic.
Straub J; Department of Hematology and Transfusion Medicine, Hospital Pelhrimov, Pelhrimov, Czech Republic.
Pika T; Department of Clinical Hematology, Hospital Novy Jicin, Novy Jicin, Czech Republic.
Cápková L; Department of Internal Medicine, Hematology and Oncology, University Hospital, Brno, Czech Republic.
Sevcíková S; Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Maisnar V; 1st Department of Medicine-Department of Hematology, First Faculty of Medicine, Charles University and General Hospital,, Prague, Czech Republic.
Hájek R; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.

Neoplasma ; 69(6): 1474-1479, 2022 Dec.

Article de En | MEDLINE | ID: mdl-36591805

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protocoles de polychimiothérapie antinéoplasique / Myélome multiple Limites: Humans Pays/Région comme sujet: Europa Langue: En Journal: Neoplasma Année: 2022 Type de document: Article Pays d'affiliation: République tchèque

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google